Bio-Techne stock hits 52-week low at 44.09 USD
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Techne Corp (TECH)
Track the Bio-Techne share price today and view real-time TECH share price data, including charts, technicals, and key financials. View the TECH premarket stock price ahead of the market session or assess the after hours quote. Explore TECH stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Bio-Techne Stock Price Today?
The Bio-Techne stock price today is 45.69.
What Is the Stock Symbol for Bio-Techne?
The stock symbol for Bio-Techne is ""TECH.""
What Stock Exchange Does Bio-Techne Trade On?
Bio-Techne is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne a Good Stock to Buy?
Determining whether Bio-Techne or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECH quote. (ISIN: US09073M1045)
What Is the Bio-Techne Stock Price Today?
The Bio-Techne stock price today is 45.69.
What Is the Stock Symbol for Bio-Techne?
The stock symbol for Bio-Techne is ""TECH.""
What Stock Exchange Does Bio-Techne Trade On?
Bio-Techne is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne a Good Stock to Buy?
Determining whether Bio-Techne or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECH quote. (ISIN: US09073M1045)
Currency in USD
45.69
+1.25(+2.82%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
44.67
46.54
52 wk Range
43.20
72.16
TECH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
44.6746.54
52 wk Range
43.2072.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TECH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
61.42
Upside
+34.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
10 analysts have revised their earnings downwards for the upcoming period
- Bio-Techne stock hits 52-week low at 44.09 USD
- Investing.com
- Form 144 BIO-TECHNE CORPORATION For: 8 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
11 Buy
4 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 61.42
(+34.42% Upside)
Bio-Techne Corp Earnings Call Summary for Q3/2026
- Bio-Techne Q3 2026 revenue fell 2% to $311.4M, missing estimates of $316.12M; adjusted EPS of $0.53 missed forecast by $0.01.
- Stock plunged 10.18% in pre-market trading to $50.91, reflecting investor disappointment with operational challenges and timing headwinds.
- Adjusted gross margin declined 120 bps to 70.4%; operating margin fell 70 bps to 34.2% year-over-year amid divestiture impacts.
- Company pursues strategic initiatives including brand consolidation and AI integration; spatial biology and proteomic platforms show growth.
- Conservative FY2027 guidance projects quarterly EPS of $0.46-$0.60; 11 analysts revised earnings downward amid biotech funding uncertainty.
Last Updated: 13/05/2026, 03:52 am
Read Full TranscriptEarnings
Latest Release
06/05/2026
EPS / Forecast
0.53 / 0.54
Revenue / Forecast
311.4M / 316.12M
Compare TECH to Peers and Sector
Metrics to compare | TECH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 65.1x | 26.4x | −0.5x | |
PEG Ratio | −3.90 | −0.31 | 0.00 | |
Price/Book | 3.4x | 2.5x | 2.6x | |
Price / LTM Sales | 5.9x | 3.3x | 3.2x | |
Upside (Analyst Target) | 39.5% | 27.3% | 55.3% | |
Fair Value Upside | Unlock | 14.3% | 9.7% | Unlock |
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bio-Techne (TECH) Stock Price Today?
The Bio-Techne stock price today is 45.69 USD.
What Stock Exchange Does Bio-Techne Trade On?
Bio-Techne is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Bio-Techne?
The stock symbol for Bio-Techne is "TECH."
Does Bio-Techne Pay Dividends? What’s The Current Dividend Yield?
The Bio-Techne dividend yield is 0.72%.
What Is the Bio-Techne Market Cap?
As of today, Bio-Techne market cap is 7.11B USD.
What Is Bio-Techne's Earnings Per Share (TTM)?
The Bio-Techne EPS (TTM) is 0.69.
When Is the Next Bio-Techne Earnings Date?
Bio-Techne will release its next earnings report on 11/08/2026.
From a Technical Analysis Perspective, Is TECH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bio-Techne Stock Split?
Bio-Techne has split 3 times.
How Many Employees Does Bio-Techne Have?
Bio-Techne has 3100 employees.
What is the current trading status of Bio-Techne (TECH)?
As of 19/05/2026, Bio-Techne (TECH) is trading at a price of 45.69 USD, with a previous close of 44.43 USD. The stock has fluctuated within a day range of 44.67 USD to 46.54 USD, while its 52-week range spans from 43.20 USD to 72.16 USD.
What Is Bio-Techne (TECH) Price Target According to Analysts?
The average 12-month price target for Bio-Techne is 61.42 USD, with a high estimate of 75 USD and a low estimate of 49 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +34.42% Upside potential.
What Is the TECH Premarket Price?
TECH's last pre-market stock price is 44.65 USD. The pre-market share volume is 890.00, and the stock has decreased by 0.22, or 0.50%.
What Is the TECH After Hours Price?
TECH's last after hours stock price is 44.51 USD, the stock has decreased by 0.08, or 0.18%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.